Kadir H. Sarun
Sydney, NSW, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Therapeutic potential of synthetic microRNA mimics based on the miR-15/107 consensus sequence.
Journal: Cancer gene therapy
Published: September 15, 2024
3-Dimensional mesothelioma spheroids provide closer to natural pathophysiological tumor microenvironment for drug response studies.
Journal: Frontiers in oncology
Published: June 20, 2022
The Role of E-Cadherin and microRNA on FAK Inhibitor Response in Malignant Pleural Mesothelioma (MPM).
Journal: International journal of molecular sciences
Published: August 09, 2021
Transcriptional suppression of the miR-15/16 family by c-Myc in malignant pleural mesothelioma.
Journal: Oncotarget
Published: February 12, 2019
Genomic Deletion of BAP1 and CDKN2A Are Useful Markers for Quality Control of Malignant Pleural Mesothelioma (MPM) Primary Cultures.
Journal: International journal of molecular sciences
Published: September 07, 2018
Dysregulated Expression of the MicroRNA miR-137 and Its Target YBX1 Contribute to the Invasive Characteristics of Malignant Pleural Mesothelioma.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: June 22, 2017
Tumor Suppressor microRNAs Contribute to the Regulation of PD-L1 Expression in Malignant Pleural Mesothelioma.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: July 14, 2016
KCa1.1, a calcium-activated potassium channel subunit alpha 1, is targeted by miR-17-5p and modulates cell migration in malignant pleural mesothelioma.
Journal: Molecular cancer
Published: October 01, 2015
Showing 1-9 of 9
Last Updated: 09/26/2026